#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medulloblastoma Scleroderma associated digital ulcer Fabry's disease Myelin oligodendrocyte glycoprotein antibody-associated disease Cortical dysplasia Progressive familial intrahepatic cholestasis Transitional cell cancer of the renal pelvis and ureter Squamous cell carcinoma of the cervix Cervix carcinoma Ependymoma Philadelphia positive chronic myeloid leukaemia Adenomatous polyposis coli Herpes simplex Systemic sclerosis pulmonary Acquired ATTR amyloidosis More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Life with Disease Mantle cell lymphoma stage II – Basic Information Hairy cell leukaemia – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Niemann-Pick disease – Life with Disease Glycogen storage disease type II – Basic Information Focal segmental glomerulosclerosis – Trials in Disease Leukoencephalopathy – Diagnostics Fragile X syndrome – Life with Disease Synovial sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dosulepin Hydrochloride Omo-103 Oditrasertib Dexrazoxane Hydrochloride Emavusertib Lysine Aspirin Ltx-315 Azd8421 PETHIDINE HYDROCHLORIDE Enpatoran Hdp-101 Mps-213 Gemcitabine Idelalisib Pbf-999 Tumour Detection Cipaglucosidase Alfa Nipocalimab Gindameran Topotecan Hydrochloride More therapies…

    Learn about Your Condition

    Hepatocellular carcinoma Dyskinesia Skin ulcer Nasopharyngeal cancer Muscle spasticity Osteosarcoma Cholecystitis acute Ischaemic stroke Ovarian epithelial cancer Laparotomy Autoimmune haemolytic anaemia Cerebellar ataxia Acute hepatic failure Meningorrhagia Gastrectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Tirzepatide
    • Cagrilintide
    • Semaglutide
    Germany Greece Hungary Poland Romania Spain

  • A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Comparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ruzasvir
    • SOFOSBUVIR
    • VELPATASVIR
    France Germany Greece Poland Romania Spain

  • Evaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia France Germany Greece Poland +1

  • Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Axatilimab
    Austria Belgium Czechia Finland France Germany +8

  • Study of ISIS 678354 for Patients with Severe High Triglycerides

    Not recruiting

    3 1
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia France Greece Hungary +9

  • Study of Isatuximab, Pomalidomide and Dexamethasone combination for multiple myeloma patients who previously received Lenalidomide and Proteasome Inhibitor therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Dexamethasone
    • Pomalidomide
    Greece

  • Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • Guselkumab
    Belgium Czechia France Germany Greece Hungary +5
Previous Page
1 … 6 7 8 9 10 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!